Myelofibrosis Clinical Trials in Minneapolis, Minnesota

4 studies are recruiting for myelofibrosis in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

    This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or high-risk primary or secondary MF.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Minnesota, Minneapolis, Minnesota
    Locations
    90 in total
    Run by
    Sumitomo Pharma America, Inc.

    See if you can join NCT04176198 on ClinicalTrials.gov

  2. Allo HSCT Using RIC and PTCy for Hematological Diseases

    This is a Phase II study following subjects proceeding with our Institutional non-myeloablative cyclophosphamide/ fludarabine/total body irradiation (TBI) preparative regimen followed by a related, unrelated, or partially matched family donor stem cell infusion using post-transplant cyclophosphamid…

    Stage
    Phase 2
    Ages
    Up to 75
    Site
    Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota
    Run by
    Masonic Cancer Center, University of Minnesota

    See if you can join NCT05805605 on ClinicalTrials.gov

  3. Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

    This is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradiation (TBI); or, fludarabine/busulfan for patients unable to receive further radiation). followed by a post-transplant graft-versus-host disease (GVH…

    Stage
    Phase 2
    Ages
    Up to 60
    Site
    Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota
    Run by
    Masonic Cancer Center, University of Minnesota

    See if you can join NCT03314974 on ClinicalTrials.gov

  4. Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

    This observational study will compare outcomes of a prospectively-enrolled cohort of Hematopoietic Stem Cell Transplant (HCT) recipients with outcomes of a cohort of age-matched historical non-HCT controls. Patients undergoing alloHCT will receive HCT in a US transplant center and be reported to th…

    Stage
    Not phased
    Ages
    55 and older
    Site
    Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota
    Run by
    Center for International Blood and Marrow Transplant Research

    See if you can join NCT02934477 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.